Taysha Gene Therapies Inc
Ownership
Ownership Structure
Who owns Taysha Gene Therapies Inc (TSHA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 71.4% of the shares are freely tradable; institutional investors hold 95.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| venBio Select Advisor LLC | 7.35 | 23,888,888 | +10.1 | 06/30/2026 |
| RA Capital Management, LLC | 7.25 | 23,555,648 | +0.0 | 06/30/2026 |
| The Goldman Sachs Group Inc | 6.99 | 22,713,118 | +1.5 | 06/30/2026 |
| BlackRock Inc | 6.37 | 20,691,927 | +12.7 | 06/30/2026 |
| Vestal Point Capital LP | 5.98 | 19,415,000 | +7.9 | 06/30/2026 |
| Morgan Stanley - Brokerage Accounts | 5.08 | 16,487,479 | -8.2 | 06/30/2026 |
| RTW INVESTMENTS, LLC | 4.17 | 13,560,258 | -0.9 | 06/30/2026 |
| FMR Inc | 4.11 | 13,336,413 | -6.9 | 06/30/2026 |
| Vanguard Capital Management, LLC | 3.84 | 12,478,595 | +22.0 | 06/30/2026 |
| State Street Corp | 3.52 | 11,421,920 | +1.9 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.